Last close As at 05/08/2026
—
— 0.00 (0.00%)
Market capitalisation
—
Research: Industrials
Blue Cap reported a strong set of FY19 results, with revenues up 28% and adjusted EBITDA up 67%. Portfolio NAV increased 8% to €128.6m or €32.31 per share, which was mainly driven by expansion in the plastics segment. The coronavirus crisis has affected Blue Cap as management now expects a low double-digit organic decline in revenues in 2020. This will not be fully compensated for by the revenue contribution of acquired Con-Pearl. 2021 is expected to be much stronger, assuming a post-coronavirus recovery leading to increased activity, and the restructuring benefits at Con-Pearl.
Blue Cap |
Steady increase in NAV and stable dividend
Industrials |
Scale research report - Update
9 June 2020 |
Share price graph
Share details
Business description
Bull
Bear
Analyst
|
||||||||||||||||||||||||||
Blue Cap reported a strong set of FY19 results, with revenues up 28% and adjusted EBITDA up 67%. Portfolio NAV increased 8% to €128.6m or €32.31 per share, which was mainly driven by expansion in the plastics segment. The coronavirus crisis has affected Blue Cap as management now expects a low double-digit organic decline in revenues in 2020. This will not be fully compensated for by the revenue contribution of acquired Con-Pearl. 2021 is expected to be much stronger, assuming a post-coronavirus recovery leading to increased activity, and the restructuring benefits at Con-Pearl.
Strong 2019 results
Blue Cap reported strong results over 2019. Revenues increased 28% to €225.6m, with organic growth at 5% and the remainder coming from the acquisitions of Knauer-Uniplast and Con-Pearl. Adjusted EBITDA showed a jump of 67% to €14.3m reflecting a margin improvement of 150bps to 6.4%. Blue Cap pays a stable dividend per share of €0.75. Net debt increased from €34m to €63m, due to acquisitions and higher leasing liabilities (IFRS 16).
Organic decline in revenues anticipated in 2020
At the beginning of the year, management was positive about Blue Cap’s outlook for 2020, but the impact of the coronavirus crisis is unavoidable. Based on the assumption that economic activity will gradually normalise towards end Q320, management expects a low double-digit organic decline in revenues for FY20. The consolidation of Con-Pearl will partly compensate for this decline. Driven by the restructuring benefits in the Plastics segment, the effect of Kurzarbeit and savings on running costs, the decline in EBITDA margin could be limited. Consensus expects a 5% decline in revenues and a 180bp lower EBITDA margin. 2021 should be much better assuming a post-coronavirus recovery and the full benefit of restructuring at Con-Pearl. M&A activity is currently low but expected to pick up in H220.
Valuation: Steady growth in NAV
Blue Cap estimates portfolio NAV of €128.6m at end FY19. Total NAV, including the NAV of the Blue Cap holding, amounts to €141.2m or €35.48 per share. If we add the positive €11m increment in NAV from the divestment of Em-Tec in April 2020, we arrive at a NAV of €152.2m or €38.24 per share. This NAV is the value per April 2020 and is before any negative effects from the coronavirus crisis. Based on consensus, Blue Cap is currently valued at an EV/EBITDA of 7.1x for 2021e, which is clearly below historical valuation levels in 2018 and 2019.
|
Consensus estimates
Source: Blue Cap, Edison, Refinitiv consensus based on one analyst (Warburg) |
Edison Investment Research provides qualitative research coverage on companies in the Deutsche Börse Scale segment in accordance with section 36 subsection 3 of the General Terms and Conditions of Deutsche Börse AG for the Regulated Unofficial Market (Freiverkehr) on Frankfurter Wertpapierbörse (as of 1 March 2017). Two to three research reports will be produced per year. Research reports do not contain Edison analyst financial forecasts.
Strong revenue growth and better margins in 2019
Blue Cap’s 2019 results were in line with the preliminary results published in April 2020. Revenues increased 28.2% to €225.6m after an increase of 25% in the first half. The main contributors to growth were acquisitions, namely Knauer-Uniplast (May 2018) and Con-Pearl (September 2019). Organic growth amounted to 5% after the reported 4% growth in the first half.
Adjusted EBITDA jumped 67% to €14.3m, reflecting a margin improvement of 150bp to 6.4%. Including several adjustments, reported net profit declined from €12.5m to €2.8m. The highest adjustment was €11.4m of badwill related to the acquisition of Knauer-Uniplast in 2018. Blue Cap will distribute a dividend per share of €0.75, which is equal to last year’s amount.
Net debt increased from €34m to €63m, due to acquisitions and the higher lease liabilities according to IFRS 16. The higher leverage will be reduced again by the potential restructuring at both Knauer-Uniplast and Con-Pearl and the divestment of Em-Tec in April 2020, which delivered a cash inflow of €25m.
Exhibit 1: Blue Cap FY19 results
€m |
FY18 |
FY19 |
Change y-o-y |
Total revenues |
176.0 |
225.6 |
28.2% |
EBITDA |
21.1 |
15.0 |
-29% |
Adjusted EBITDA |
8.6 |
14.3 |
67% |
Adjusted EBITDA margin |
4.9% |
6.4% |
|
EBIT |
14.0 |
4.6 |
-67% |
Adjusted EBIT |
3.3 |
6.8 |
109% |
Net profit |
12.5 |
2.8 |
-78% |
Number of shares outstanding (m) |
3.98 |
3.98 |
|
EPS (€) |
3.14 |
0.71 |
-78% |
DPS (€) |
0.75 |
0.75 |
Source: Blue Cap accounts, Edison Investment Research
Segment performance
Blue Cap’s strategic focus is on industrial companies in the DACH region. In 2019, revenues based on customer location were as follows: Germany 52%, rest of Europe 34%, rest of World 14%.
Looking at activities, the company’s focus is on companies that are active in the coating, adhesives and plastics sectors. Blue Cap reports in six segments, which are shown in Exhibit 2. Coatings and Adhesives showed stable development in 2019, but Plastics reported a jump in revenues of 93%, which is largely driven by the acquisitions Knauer-Uniplast (four additional months, given that it was consolidated per 1 May 2018) and Con-Pearl (consolidated since September 2019). Production increased 21%, driven by Gämmerler and SMD-David, while Nokra reported a decline in revenues. Medical’s reported revenues were 1% below last year’s level, but this was fully due to the divestment of Wisap Medical Technology. Excluding this effect, revenues in Medical were about 20% higher compared to last year. Precious metals showed a jump of 85% in revenues, benefiting from the higher price for gold.
Exhibit 2: Revenues per segment FY19, €m
Segments |
Included companies |
Revenues FY18 |
Revenues FY19 |
Change y-o-y |
Coatings |
Neschen |
61.1 |
62.2 |
1.9% |
Adhesives |
Planatol |
36.5 |
35.7 |
-2.2% |
Plastics |
Knauer-Uniplast, Con-Pearl |
37.7 |
72.8 |
92.9% |
Production |
Gämmerler, SMB-David, Nokra |
17.8 |
21.6 |
21.0% |
Medical |
Em-Tec |
10.6 |
10.5 |
-1.0% |
Precious metals |
Carl Schaefer |
12.5 |
23.2 |
85.3% |
Other |
(0.3) |
(0.3) |
4.1% |
|
Total revenues |
176.0 |
225.7 |
28.2% |
Source: Blue Cap accounts, Edison Investment Research
Outlook: Lower organic revenues in 2020
Blue Cap’s management was very positive at the start of 2020 about its growth opportunities during the current financial year. Also, Con-Pearl was acquired in September 2019 and therefore will contribute significantly to the FY20 revenues (it contributed €17m to FY19 revenues while having annual revenues of €55.4m), while going through a reorganisation process this year.
Effective April 2020, Blue Cap sold Em-Tec to Dover Corporation for a cash inflow of €25m, which compares positively to the FY19 NAV of €14m for this asset. This sale fits the company’s strategy to focus on companies within the revenue range of €30–80m.
Due to the unavoidable effect of the coronavirus crisis, management has adjusted its expectations for 2020. Management assumes a gradual normalisation of economic activity towards the end of the third quarter and expects revenues to show a low double-digit organic decline. The contribution of Con-Pearl will bring compensation and easily offset the loss of revenues of Em-Tec, but its contribution will not be enough to generate overall revenue growth in FY20. Consensus currently expects a 5% decline in total revenues.
The company’s diversification strategy is paying off as the business units are affected differently by the current crisis. Knauer-Uniplast benefits from increased demand in the food sector, Carl Schaeffer benefits from the rising gold price and Inheco (minority stake) benefits from higher demand for laboratory automation products. On the other hand, Con-Pearl is affected by the decline in the automotive sector and both Neschen and Planatol face declining demand from the graphic industry.
M&A will remain an important driver for growth, but due to the coronavirus crisis management expects M&A activity to be temporarily low and pick up again as of the second half of 2020.
Valuation: Steady growth in NAV
Blue Cap values its business units by using a discounted cash flow model, which is based on the individual FY19 results and the approved budgets for the years 2020 to 2022. Blue Cap assumes an average perpetual growth rate of 1.5% (FY18: 2.0%) and an average WACC of 6.1% (FY18: 7.5%). Exhibit 3 below shows the development of the NAV in 2018 and 2019 of the various business units of Blue Cap. The NAV of the total portfolio increased 8.8% to €128.6m. The major change came from Plastics, where Blue Cap added Con-Pearl to its portfolio in September 2019.
Exhibit 3: NAV of Blue Cap’s business units, €m
Segments |
NAV FY18 |
NAV FY19 |
Change y-o-y |
Coatings |
61.1 |
60.9 |
-0.3% |
Adhesives |
15.7 |
15.9 |
1.3% |
Plastics |
10.7 |
22.1 |
106.5% |
Production |
15.9 |
12.2 |
-23.3% |
Medical |
11.6 |
14.0 |
20.7% |
Precious metals |
3.2 |
3.5 |
9.4% |
Total |
118.2 |
128.6 |
8.8% |
Source: Blue Cap accounts, Edison Investment Research
This NAV excludes the net debt at holding level (€2.8m), the book value of real estate (€12.4m) and the book value of minority stakes (€3.0m). Including these items, the overall NAV is €141.2m, reflecting a value per share of €35.48. Including the Em-Tec transaction, while assuming all other factors unchanged, would lift the total NAV of Blue Cap by €11m to €152.2m, or €38.24 per share. This amount reflects the NAV per April 2020 and does not take into account any negative effects from the coronavirus crisis.
This adjusted NAV per share compares to the current share price of the company of €16.70. The current share price of Blue Cap is generally in line with the book value per share of €16.80.
|
Exhibit 4: Development of Blue Cap’s NAV |
|
|
Source: Blue Cap accounts, Edison Investment Research |
Based on Refinitiv consensus estimates, Blue Cap is currently valued at an EV/EBITDA of 7.1x for 2021e, which is relatively low when compared to the company’s historical EV/EBITDA multiples in 2018 and 2019 of 11.7x and 9.6x, respectively.
|
||||||||||||
Research: TMT
Allied Minds made significant progress in FY19, focusing on its slimmed down portfolio of seven investee companies, with strategic funding rounds for Federated Wireless (FW) and HawkEye 360, before the sale of HawkEye 360. Recurring central costs have been cut to $6m in FY20, with a headcount of seven. Post the period-end, FW announced partnerships with AWS and Microsoft Azure with initial revenues expected in FY20. Parent cash at 31 December 2019 was $84.1m. The company no longer discloses NAV, but we estimate net cash at 4 June 2020 of $31.9m (adjusted for the 12.6p special dividend, investments and costs) and NAV of 90.9p/share (78.4p/share fully diluted). Based on seemingly conservative valuations, the shares trade at a 56–62% discount to our estimated NAV.